NSE · JHS
JHS Svendgaard Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,125
of 5,096 stocks
🏆 New peak
▲ 181W
Peak #3,125 · 28 Sep 2026
Operating in Healthcare, JHS Svendgaard Laboratories Limited has a subdued return on equity, is growing revenue at a solid clip, and has promoters holding 34%.
Market Cap
77.00 Cr
P/E Ratio
—
P/B Ratio
0.44
ROE
-1.10%
ROCE
-0.78%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 30.38 Cr | 32.70 Cr | 23.27 Cr | 22.28 Cr |
| Net Profit | 1.09 Cr | -3.57 Cr | 78.89 L | -19.78 L |
| EPS | 0.12 | -0.42 | 0.09 | 0.02 |
| Operating Profit | 34.58 L | -2.76 Cr | 35.68 L | 18.49 L |
Shareholding pattern
Promoter
33.85%
Public
66.15%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 11 Sep 2023 | Other | Demerger |
| 06 Sep 2019 | Other | Annual General Meeting |
| 03 Sep 2018 | Other | Annual General Meeting |
| 21 Aug 2017 | Other | Annual General Meeting |
| 02 Jan 2017 | Other | Extra Ordinary General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.